Hornigold, Nick
Dunn, Karen R.
Craven, Rachel A.
Zougman, Alexandre
Trainor, Sebastian
Shreeve, Rebecca
Brown, Joanne
Sewell, Helen
Shires, Michael
Knowles, Margaret
Fukuwatari, Tsutomu
Maher, Eamonn R.
Burns, Julie
Bhattarai, Selina
Menon, Mini
Brazma, Alvis
Scelo, Ghislaine
Feulner, Lara
Riazalhosseini, Yasser
Lathrop, Mark
Harris, Adrian
Selby, Peter J.
Banks, Rosamonde E.
Vasudev, Naveen S. http://orcid.org/0000-0001-8470-7481
Article History
Received: 14 November 2019
Accepted: 15 April 2020
First Online: 11 May 2020
Ethics approval and consent to participate
: The study was approved by the Leeds East Research Ethics Committee (ethical approval 15/YH/0080) and performed in accordance with the Declaration of Helsinki. All samples were obtained with the patients’ informed consent.
: No individually identifiable data are presented.
: RNA-seq data, generated through our ICGC CAGEKID study, has been deposited in a public repository as described elsewhere: Scelo et al.<sup>30</sup> Proteomic data sets are available on request.
: A.H. is Editor-in-Chief of <i>British Journal of Cancer</i>. R.S.’s current role is Publishing Editor for <i>British Journal of Cancer</i>.
: This work was supported by funding from the University of Leeds and Cancer Research UK. E.R.M. is funded by the European Research Council (Advanced Researcher Award), NIHR (Senior Investigator Award and Cambridge NIHR Biomedical Research Centre) and Cancer Research UK Cambridge Cancer Centre. The views expressed are those of the authors and not necessarily those of the NHS or Department of Health. The University of Cambridge has received salary support in respect of E.R.M. from the NHS in the East of England through the Clinical Academic Reserve.